These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab. Torres T; Vilaça S; Velho G; Selores M Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198 [No Abstract] [Full Text] [Related]
5. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment. Krueger GG Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383 [No Abstract] [Full Text] [Related]
9. Interleukin-17 inhibition: a route to psoriasis clearance? Bachelez H Lancet; 2015 Aug; 386(9993):510-2. PubMed ID: 26072106 [No Abstract] [Full Text] [Related]
10. Safety and efficacy study on etanercept in patients with plaque psoriasis. Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833 [No Abstract] [Full Text] [Related]
11. Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis. Wan J; Abuabara K; Troxel AB; Shin DB; Van Voorhees AS; Bebo BF; Krueger GG; Callis Duffin K; Gelfand JM Arch Dermatol; 2012 Apr; 148(4):539-41. PubMed ID: 22508884 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C. Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749 [No Abstract] [Full Text] [Related]
13. Adalimumab vs. etanercept in psoriasis. Downs AM Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064 [No Abstract] [Full Text] [Related]
14. Psoriasis: Is ustekinumab superior to etanercept for psoriasis? Kuhn A; Luger TA Nat Rev Rheumatol; 2010 Sep; 6(9):500-1. PubMed ID: 20808304 [No Abstract] [Full Text] [Related]
15. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study. Woolf RT; Smith CH; Robertson K; Barker JN Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408 [No Abstract] [Full Text] [Related]
16. 'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network. van den Reek JM; Zweegers J; Kievit W; Otero ME; van Lümig PP; Driessen RJ; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; van de Kerkhof PC; Seyger MM; de Jong EM Br J Dermatol; 2014 Nov; 171(5):1189-96. PubMed ID: 24807471 [TBL] [Abstract][Full Text] [Related]
17. Severe generalized exanthema due to etanercept given for severe plaque psoriasis. Gonzalo-Garijo MA; Pérez-Calderón R; de Argila Fernández-Durán D Ann Allergy Asthma Immunol; 2008 Jun; 100(6):621-2. PubMed ID: 18592833 [No Abstract] [Full Text] [Related]
18. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept]. Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851 [No Abstract] [Full Text] [Related]
19. Survival rate of etanercept for psoriasis in real life: a multicentre observational study. Herrera-Acosta E; Suárez-Pérez JA; Aguilera J; Gómez-García F; Jiménez-Puya R; Guimerá F; Mendiola MV; Herrera-Ceballos E Eur J Dermatol; 2014; 24(5):619-20. PubMed ID: 25115194 [No Abstract] [Full Text] [Related]
20. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions]. Paul C; Solignac M Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165 [No Abstract] [Full Text] [Related] [Next] [New Search]